BioCatalyst

DSGN — Design Therapeutics, Inc. catalysts

1 verified catalyst event(s) for Design Therapeutics, Inc. (ticker DSGN). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-09-01 — DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09 (month)
in 2mo
ESTIMATED
 READOUT
DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy
Phase 2 · Fuchs Endothelial Corneal Dystrophy, Fuchs
 DSGN Design Therapeutics, Inc. DT-168 ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.